GET THE APP

Pancreatic Disorders & Therapy

Pancreatic Disorders & Therapy
Open Access

ISSN: 2165-7092

+44 1478 350008

Pancreatic Disorders & Therapy : Citations & Metrics Report

Articles published in Pancreatic Disorders & Therapy have been cited by esteemed scholars and scientists all around the world. Pancreatic Disorders & Therapy has got h-index 11, which means every article in Pancreatic Disorders & Therapy has got 11 average citations.

Following are the list of articles that have cited the articles published in Pancreatic Disorders & Therapy.

  2022 2021 2020 2019 2018

Year wise published articles

30 28 9 1 7

Year wise citations received

43 44 64 43 36
Journal total citations count 437
Journal impact factor 1.58
Journal 5 years impact factor 3.08
Journal cite score 3.74
Journal h-index 11
Journal h-index since 2018 9
Important citations (368)

Commentary on “acute pancreatitis as initial demonstration of drug- induced vasculitis”

current trends in pharmacological approaches for treatment and management of acute pancreatitis - a review.

does pendimethalin develop in pancreatic cancer induced inflammation

design, synthesis, and biological evaluation of novel 5-substituted-2-(3,4,5-trihydroxyphenyl)-1,3,4-oxadiazoles as potent antioxidants

carvacrol modulates oxidative stress and decreases cell injury in pancreas of rats with acute pancreatitis

antioxidant therapy in pancreatitis

low dose of carvacrol prevents rat pancreas tissue damage after l-arginine application, while higher doses cause pancreatic tissue impairment

trpm2 channel-mediated cell death: an important mechanism linking oxidative stress-inducing pathological factors to associated pathological conditions.

pretreatment with obestatin reduces the severity of ischemia/reperfusion-induced acute pancreatitis in rats.

antioxidant therapy in acute, chronic and post-endoscopic retrograde cholangiopancreatography pancreatitis: an updated systematic review and meta-analysis.

Synthetic triterpenoid rta dh404 (cddo-dhtfea) ameliorates acute pancreatitis

rcan1 is a marker of oxidative stress, induced in acute pancreatitis

dclk1 regulates pluripotency and angiogenic factors via microrna-dependent mechanisms in pancreatic cancer

xmd8-92 inhibits pancreatic tumor xenograft growth via a dclk1-dependent mechanism

pancreatic surgery with vascular reconstruction in patients with locally advanced pancreatic neuroendocrine tumors

role of jnk signalling and ahr in fibrosis, implications for new therapeutics

novel combination therapy boosts the host immune system, destroys free radicals and targets the critical flaw in chronic pancreatic disease

role of jnk signalling and ahr in fibrosis, implications for new

the role of endoscopic ultrasound (eus) in the management of patients with pancreatic cancer: now bigger than ever

phase i clinical trial of peptide vaccination with urlc10 and vegfr1 epitope peptides in patients with advanced gastric cancer

Relevant Topics

Top